Clinical Trial Update: Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trastuzumab for locally advanced or metastatic gallbladder cancer or bile duct cancer that cannot be surgically removed; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Extrahepatic Bile Duct
• Adenocarcinoma of the Gallbladder
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer
• Malignant Neoplasm of Extrahepatic Bile Duct
• Unresectable Extrahepatic Bile Duct Cancer
• Unresectable Gallbladder Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder | Phase 2 | Status: TERMINATED | Results posted: 2013-11-19